Cite
Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review.
MLA
Hiramatsu, Katsutoshi, and Hideki Maeda. “Adult and Pediatric Relapsing Multiple Sclerosis Phase II and Phase III Trial Design and Their Primary End Points: A Systematic Review.” CTS: Clinical & Translational Science, vol. 17, no. 5, May 2024, pp. 1–54. EBSCOhost, https://doi.org/10.1111/cts.13794.
APA
Hiramatsu, K., & Maeda, H. (2024). Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review. CTS: Clinical & Translational Science, 17(5), 1–54. https://doi.org/10.1111/cts.13794
Chicago
Hiramatsu, Katsutoshi, and Hideki Maeda. 2024. “Adult and Pediatric Relapsing Multiple Sclerosis Phase II and Phase III Trial Design and Their Primary End Points: A Systematic Review.” CTS: Clinical & Translational Science 17 (5): 1–54. doi:10.1111/cts.13794.